Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Selection of Shock Energy in Out-Of-Hospital Cardiac Arrest

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Charite University, Berlin, Germany.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT00472147
First received: May 10, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

Sudden cardiac death is the most frequent cause of death in industrialized countries. The most efficient interventiont in ventricular fibrillation is defibrillation in an appropriate timely manner. But since the intervention of defibrillation the optimal shock energy is unknown. As a too low energy is not able to terminate ventricular fibrillation a too high energy may cause asystole wich jeopardizes survival itself. We study the efficacy of different shock energies on the termination of ventricular fibrillatiion and survival.


Condition Intervention
Sudden Cardiac Death
Arrhythmia
Survival
Procedure: shock efficacy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • termination of vf survival

Secondary Outcome Measures:
  • resulting rhythm CPC score

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • out of hospital sudden cardiac death
  • ventricular fibrillation

Exclusion Criteria:

  • non cardiac death
  • asystole
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472147

Contacts
Contact: Dirk Müller, MD, PhD +49 30 8445 ext 3554 dr.dirk.mueller@charite.de
Contact: Hans-Richard Arntz, MD, PhD +49 30 8445 ext 2640 hans-richard.arntz@charite.de

Locations
Germany
Charité campus Benjamin Franklin
Berlin, Germany, 12200
Sponsors and Collaborators
Charite University, Berlin, Germany
Investigators
Principal Investigator: Dirk Müller, MD, PhD Charité, Campus Benjamin Franklin
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00472147     History of Changes
Other Study ID Numbers: CBF-2007002
Study First Received: May 10, 2007
Last Updated: May 10, 2007
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Additional relevant MeSH terms:
Death, Sudden, Cardiac
Out-of-Hospital Cardiac Arrest
Cardiovascular Diseases
Death
Death, Sudden
Heart Arrest
Heart Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on November 20, 2014